Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    BMS-241027
Show Display Options
Rank Status Study
1 Completed Study to Evaluate the Safety, Tolerability and the Effect of BMS-241027 on Cerebrospinal Fluid Biomarkers in Subjects With Mild Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Drug: BMS-241027;   Drug: Placebo matching BMS-241027

Indicates status has not been verified in more than two years